Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1989 Nov;86(22):9020–9024. doi: 10.1073/pnas.86.22.9020

Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments.

A M Graybiel 1, R Moratalla 1
PMCID: PMC298424  PMID: 2813436

Abstract

A major mechanism of neurotransmitter inactivation at catecholaminergic synapses is reuptake of released transmitter at high-affinity uptake sites on presynaptic terminals. We have analyzed the anatomical distribution of site-selective ligand binding for dopamine uptake sites in the striatum of rat, cat, and monkey. We report here that desipramine-sensitive [3H]mazindol binding sites have highly heterogeneous distributions in the dorsal and the ventral striatum. In the caudate nucleus of cat and monkey, [3H]mazindol binding observes striosomal ordering, being reduced in striosomes and heightened in the extrastriosomal matrix. Some local heterogeneity appears in the ventral caudoputamen of the rat. Different subdivisions of the nucleus accumbens also have different binding levels. These findings suggest that some functional effects of psychoactive drugs, such as cocaine, that bind to the dopamine-uptake complex could be related to the distribution of these specific uptake sites. The findings also raise the possibility that these distributions could result in selective neuronal vulnerability to neurotoxins, such as 1-methyl-4-phenylpyridine (MPP+), that depend on the dopamine-uptake complex for entry into neurons.

Full text

PDF
9020

Images in this article

9021Image
on p.9021
9021Image
on p.9021
9022Image
on p.9022
9023Image
on p.9023

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Besson M. J., Graybiel A. M., Nastuk M. A. [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience. 1988 Jul;26(1):101–119. doi: 10.1016/0306-4522(88)90130-3. [DOI] [PubMed] [Google Scholar]
  2. Bradbury A. J., Costall B., Jenner P. G., Kelly M. E., Marsden C. D., Naylor R. J. MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal area. Neuropharmacology. 1986 Aug;25(8):939–941. doi: 10.1016/0028-3908(86)90025-0. [DOI] [PubMed] [Google Scholar]
  3. Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., Kopin I. J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4546–4550. doi: 10.1073/pnas.80.14.4546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chiba K., Trevor A. J., Castagnoli N., Jr Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes. Biochem Biophys Res Commun. 1985 May 16;128(3):1228–1232. doi: 10.1016/0006-291x(85)91071-x. [DOI] [PubMed] [Google Scholar]
  5. Davis G. C., Williams A. C., Markey S. P., Ebert M. H., Caine E. D., Reichert C. M., Kopin I. J. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1979 Dec;1(3):249–254. doi: 10.1016/0165-1781(79)90006-4. [DOI] [PubMed] [Google Scholar]
  6. Deutch A. Y., Elsworth J. D., Goldstein M., Fuxe K., Redmond D. E., Jr, Sladek J. R., Jr, Roth R. H. Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci Lett. 1986 Jul 11;68(1):51–56. doi: 10.1016/0304-3940(86)90228-4. [DOI] [PubMed] [Google Scholar]
  7. Ferrante R. J., Kowall N. W. Tyrosine hydroxylase-like immunoreactivity is distributed in the matrix compartment of normal human and Huntington's disease striatum. Brain Res. 1987 Jul 21;416(1):141–146. doi: 10.1016/0006-8993(87)91506-x. [DOI] [PubMed] [Google Scholar]
  8. Geneser-Jensen F. A., Blackstad T. W. Distribution of acetyl cholinesterase in the hippocampal region of the guinea pig. I. Entorhinal area, parasubiculum, and presubiculum. Z Zellforsch Mikrosk Anat. 1971;114(4):460–481. doi: 10.1007/BF00325634. [DOI] [PubMed] [Google Scholar]
  9. Gerfen C. R., Herkenham M., Thibault J. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci. 1987 Dec;7(12):3915–3934. doi: 10.1523/JNEUROSCI.07-12-03915.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. German D. C., Dubach M., Askari S., Speciale S. G., Bowden D. M. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost? Neuroscience. 1988 Jan;24(1):161–174. doi: 10.1016/0306-4522(88)90320-x. [DOI] [PubMed] [Google Scholar]
  11. Graybiel A. M., Hirsch E. C., Agid Y. A. Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity. Proc Natl Acad Sci U S A. 1987 Jan;84(1):303–307. doi: 10.1073/pnas.84.1.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Graybiel A. M., Ragsdale C. W., Jr Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5723–5726. doi: 10.1073/pnas.75.11.5723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Heikkila R. E., Cabbat F. S., Duvoisin R. C. Motor activity and rotational behavior after analogs of cocaine: correlation with dopamine uptake blockade. Commun Psychopharmacol. 1979;3(5):285–290. [PubMed] [Google Scholar]
  14. Imai H., Nakamura T., Endo K., Narabayashi H. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology. Brain Res. 1988 Dec 6;474(2):327–332. doi: 10.1016/0006-8993(88)90446-5. [DOI] [PubMed] [Google Scholar]
  15. Javitch J. A., D'Amato R. J., Strittmatter S. M., Snyder S. H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci U S A. 1985 Apr;82(7):2173–2177. doi: 10.1073/pnas.82.7.2173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Javitch J. A., Strittmatter S. M., Snyder S. H. Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography. J Neurosci. 1985 Jun;5(6):1513–1521. doi: 10.1523/JNEUROSCI.05-06-01513.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jimenez-Castellanos J., Graybiel A. M. Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix. Neuroscience. 1987 Oct;23(1):223–242. doi: 10.1016/0306-4522(87)90285-5. [DOI] [PubMed] [Google Scholar]
  18. Joyce J. N., Sapp D. W., Marshall J. F. Human striatal dopamine receptors are organized in compartments. Proc Natl Acad Sci U S A. 1986 Oct;83(20):8002–8006. doi: 10.1073/pnas.83.20.8002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kelly P. H., Seviour P. W., Iversen S. D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 1975 Sep 5;94(3):507–522. doi: 10.1016/0006-8993(75)90233-4. [DOI] [PubMed] [Google Scholar]
  20. Kennedy L. T., Hanbauer I. Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites. J Neurochem. 1983 Jul;41(1):172–178. doi: 10.1111/j.1471-4159.1983.tb13666.x. [DOI] [PubMed] [Google Scholar]
  21. Langer L. F., Graybiel A. M. Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum. Brain Res. 1989 Oct 2;498(2):344–350. doi: 10.1016/0006-8993(89)91114-1. [DOI] [PubMed] [Google Scholar]
  22. Langston J. W., Ballard P., Tetrud J. W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983 Feb 25;219(4587):979–980. doi: 10.1126/science.6823561. [DOI] [PubMed] [Google Scholar]
  23. Li S. J., Sivam S. P., McGinty J. F., Jiang H. K., Douglass J., Calavetta L., Hong J. S. Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J Pharmacol Exp Ther. 1988 Jul;246(1):403–408. [PubMed] [Google Scholar]
  24. O'Dell S. J., Marshall J. F. Transport of [3H]mazindol binding sites in mesostriatal dopamine axons. Brain Res. 1988 Sep 20;460(2):402–406. doi: 10.1016/0006-8993(88)90391-5. [DOI] [PubMed] [Google Scholar]
  25. Olson L., Seiger A., Fuxe K. Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. Brain Res. 1972 Sep 15;44(1):283–288. doi: 10.1016/0006-8993(72)90385-x. [DOI] [PubMed] [Google Scholar]
  26. Pileblad E., Carlsson A. Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain. Neuropharmacology. 1985 Jul;24(7):689–692. doi: 10.1016/0028-3908(85)90114-5. [DOI] [PubMed] [Google Scholar]
  27. Ricaurte G. A., Langston J. W., DeLanney L. E., Irwin I., Brooks J. D. Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum. Neurosci Lett. 1985 Sep 6;59(3):259–264. doi: 10.1016/0304-3940(85)90141-7. [DOI] [PubMed] [Google Scholar]
  28. Ritz M. C., Lamb R. J., Goldberg S. R., Kuhar M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 1987 Sep 4;237(4819):1219–1223. doi: 10.1126/science.2820058. [DOI] [PubMed] [Google Scholar]
  29. Schultz W., Scarnati E., Sundström E., Tsutsumi T., Jonsson G. The catecholamine uptake blocker nomifensine protects against MPTP-induced parkinsonism in monkeys. Exp Brain Res. 1986;63(1):216–220. doi: 10.1007/BF00235666. [DOI] [PubMed] [Google Scholar]
  30. Sundström E., Goldstein M., Jonsson G. Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice. Eur J Pharmacol. 1986 Nov 19;131(2-3):289–292. doi: 10.1016/0014-2999(86)90585-6. [DOI] [PubMed] [Google Scholar]
  31. Turner B. H., Wilson J. S., McKenzie J. C., Richtand N. MPTP produces a pattern of nigrostriatal degeneration which coincides with the mosaic organization of the caudate nucleus. Brain Res. 1988 Nov 8;473(1):60–64. doi: 10.1016/0006-8993(88)90315-0. [DOI] [PubMed] [Google Scholar]
  32. Wilson J. S., Turner B. H., Morrow G. D., Hartman P. J. MPTP produces a mosaic-like pattern of terminal degeneration in the caudate nucleus of dog. Brain Res. 1987 Oct 13;423(1-2):329–332. doi: 10.1016/0006-8993(87)90857-2. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES